{"database": "openregs", "table": "documents", "rows": [["FDA-2024-N-1636-0002", "FDA", "FDA-2024-N-1636", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; KEBILIDI (eladocagene exuparvovectneq)", "Notice", "Announcement", "2024-12-02T05:00:00Z", 2024, 12, "2024-12-02T05:00:00Z", null, "2024-12-02T15:11:50Z", "2024-28206", 0, 0, "0900006486843d8e"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2024-N-1636-0002"], "units": {}, "query_ms": 0.429196996265091, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}